911 — Qianhai Health Holdings Cashflow Statement
0.000.00%
- HK$47.44m
- HK$28.41m
- HK$961.29m
Annual cashflow statement for Qianhai Health Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 26.7 | -0.804 | -0.888 | -234 | -52.7 |
Depreciation | |||||
Non-Cash Items | -14.6 | 25 | -1.38 | 292 | 1.51 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -393 | -98.1 | -44.3 | -66.2 | 49.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -379 | -70.9 | -44.2 | -5.26 | 0.857 |
Capital Expenditures | -33.1 | -0.01 | -0.009 | -0.004 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 220 | 122 | 46.9 | 12.3 | 17.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 187 | 122 | 46.8 | 12.3 | 17.8 |
Financing Cash Flow Items | -0.872 | -2.31 | -0.53 | -0.034 | -0.043 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 73.3 | -55.2 | -16.6 | -7.91 | -0.743 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -118 | -3.63 | -13.9 | -0.828 | 17.9 |